Mathieu Bourdenx
Impact in
Papers in
- Neurology 17
- Parkinson's Disease Mechanisms and Treatments 17
- Neurological disorders and treatments 4
- Physiology 12
- Alzheimer's disease research and treatments 9
- Lysosomal Storage Disorders Research 4
- Co-authors
- Benjamin Dehay (18 shared papers)Erwan Bézard (21 shared papers)Ana María Cuervo (5 shared papers)Aurora Scrivo (2 shared papers)Olatz Pampliega (2 shared papers)Wassilios G. Meissner (5 shared papers)Federico N. Soria (2 shared papers)Miquel Vila (3 shared papers)
- Journals
- Neurobiology of Disease (3 papers)Nature Cell Biology (2 papers)The Lancet Neurology (2 papers)PLoS Biology (2 papers)Autophagy (2 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Mathieu Bourdenx
32 papers receiving 2.3k citations
Mathieu Bourdenx's Hit Papers
Peers
Comparison fields: 5 of 107
- Neurology 705
- Neurology 275
- Aging 47
- Physiology 606
- Physiology 114
Countries citing papers authored by Mathieu Bourdenx
This map shows the geographic impact of Mathieu Bourdenx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Bourdenx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Bourdenx more than expected).
Fields of papers citing papers by Mathieu Bourdenx
This network shows the impact of papers produced by Mathieu Bourdenx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Bourdenx. The network helps show where Mathieu Bourdenx may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Bourdenx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations Hit paper breakdown → | 2015 | 396 |
| 2 | The different autophagy degradation pathways and neurodegeneration Hit paper breakdown → | 2022 | 317 |
| 3 | Selective autophagy as a potential therapeutic target for neurodegenerative disorders Hit paper breakdown → | 2018 | 283 |
| 4 | 2019 | 177 | |
| 5 | 2016 | 165 | |
| 6 | 2015 | 145 | |
| 7 | 2017 | 116 | |
| 8 | 2017 | 94 | |
| 9 | 2014 | 72 | |
| 10 | 2014 | 65 | |
| 11 | 2014 | 64 | |
| 12 | 2019 | 56 | |
| 13 | 2021 | 53 | |
| 14 | 2021 | 41 | |
| 15 | 2016 | 30 | |
| 16 | 2023 | 29 | |
| 17 | 2024 | 25 | |
| 18 | 2016 | 22 | |
| 19 | 2020 | 22 | |
| 20 | 2017 | 21 |
About Mathieu Bourdenx
Mathieu Bourdenx is a scholar working on Neurology, Physiology, Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience, having authored 32 papers that have together received 2.3k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (17 papers), Alzheimer's disease research and treatments (9 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Autophagy in Disease and Therapy (5 papers), RNA Interference and Gene Delivery (4 papers), Neurological disorders and treatments (4 papers), Lysosomal Storage Disorders Research (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). The work is most often cited by research in Neurology (705 citations), Neurology (275 citations), Aging (47 citations), Physiology (606 citations) and Physiology (114 citations). Mathieu Bourdenx has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Benjamin Dehay, Erwan Bézard, Ana María Cuervo, Aurora Scrivo, Olatz Pampliega, Wassilios G. Meissner, Federico N. Soria, Miquel Vila, Gregory A. Petsko and Andrew Singleton. Their work appears in journals such as Neurobiology of Disease, Nature Cell Biology, The Lancet Neurology, PLoS Biology and Autophagy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.